SCHEMBL6916017

SCHEMBL6916017

CCOC(=O)c1cc(C(C)(C)C)c(OC)c(C(C)(C)C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.51
CA1 P00915 3/20 0.51
CA2 P00918 3/20 0.51
CA7 P43166 3/20 0.51
CA9 Q16790 3/20 0.51
CA14 Q9ULX7 3/20 0.51
TNFRSF1A P19438 2/20 0.47
HSD17B2 P37059 1/20 0.46
UBE2N P61088 1/20 0.43
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
BCL2L1 Q07817 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAOA P21397 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7944853 0.84 TNFRSF1A (0.45) TNFRSF1AGAALMNACYP3A4MEN1
SCHEMBL6918210 0.83 CA2 (0.59) CA12CA1CA2CA7CA9
SCHEMBL5677096 0.82 TNFRSF1A (0.51) CA12CA1CA2CA7CA9
SCHEMBL7933789 0.81 SCN1A (0.47) TNFRSF1AESR1LMNACYP3A4MEN1
SCHEMBL7933132 0.81 CA12 (0.53) CA12CA1CA2CA7CA9
SCHEMBL7933594 0.80 SLC29A1 (0.47) TNFRSF1AESR1LMNACYP3A4MEN1
Methylamine SCHEMBL8647392 0.80 CA2 (0.56) CA12CA1CA2CA7CA9
SCHEMBL7943237 0.80 TNFRSF1A (0.40) TNFRSF1AESR1GAALMNACYP3A4
SCHEMBL21376220 0.80 HSD17B2 (0.61) CA12CA1CA2CA7CA9
SCHEMBL27871656 0.79 TNFRSF1A (0.49) TNFRSF1AGAALMNACYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004026245-A2 SUBSTITUTED PHOSPHONATE COMPOUNDS HAVING BONE ANABOLIC ACTIVITY ILEX ONCOLOGY RESEARCH, SARL (CH) 2004-04-01 WO disclosed